BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31287410)

  • 1. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
    Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
    J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
    Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
    Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
    Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Han MH; Kwon JE; Yim H; Kim HA
    Sci Rep; 2017 Apr; 7():46652. PubMed ID: 28436448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
    Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
    Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
    Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
    Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
    J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
    Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
    Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
    Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
    J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still's disease.
    Han JH; Ahn MH; Jung JY; Kim JW; Suh CH; Kwon JE; Yim H; Kim HA
    Sci Rep; 2022 Jun; 12(1):10240. PubMed ID: 35715478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.